1.8.98.2: sulfiredoxin
This is an abbreviated version!
For detailed information about sulfiredoxin, go to the full flat file.

Word Map on EC 1.8.98.2
-
1.8.98.2
-
peroxiredoxins
-
hyperoxidation
-
thioredoxins
-
overoxidized
-
sulfenic
-
peroxidatic
-
txnrd1
-
sulfinylated
-
deglutathionylation
-
prxiii
-
prdxs
-
cys-so2h
-
medicine
-
drug development
- 1.8.98.2
- peroxiredoxins
-
hyperoxidation
- thioredoxins
-
overoxidized
-
sulfenic
-
peroxidatic
- txnrd1
-
sulfinylated
-
deglutathionylation
-
prxiii
-
prdxs
-
cys-so2h
- medicine
- drug development
Reaction
Synonyms
AtSrx, cysteine-sulfinic acid reductase, neoplastic progression 3, peroxiredoxin-(S-hydroxy-S-oxocysteine) reductase, protein cysteine sulfinic acid reductase, Srx, Srx1, Srxn1, sulfiredoxin, sulfiredoxin 1, sulfiredoxin-1, sulphiredoxin
ECTree
Advanced search results
Results
in table
1
1793
17
50
26
54
Application
Application on EC 1.8.98.2 - sulfiredoxin
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
diagnostics
the lung cancer patients with high Srx levels have significantly shorter survival and those with high TXNDC5 levels have longer survival. Cellular levels of Srx and TXNDC5 may be useful as biomarkers to predict the survival of individuals with lung cancer
drug development
-
Srx may be a potential target for prevention or treatment of cancer, the colorimetric assay would be useful for high-throughput screening of Srx inhibitors as demonstrated
medicine
-
increased sulfiredoxin has been linked with oncogenic transformation, data support a role for Srx in controlling the phosphorylation status of key regulatory kinases
medicine
-
oxidative stress results in protein oxidation and is involved in the pathogenesis of lung diseases such as chronic obstructive pulmonary disorder, COPD, in lungs from COPD patients the expression of Srx1 is dramatically decreased
medicine
-
oxidative stress results in protein oxidation and is involved in the pathogenesis of lung diseases such as chronic obstructive pulmonary disorder, COPD, in lungs from COPD patients the expression of Srx1 is dramatically decreased